Canopy Growth Corporation Stock

Equities

WEED

CA1380357048

Pharmaceuticals

Market Closed - Toronto S.E. 04:00:00 2024-06-07 pm EDT 5-day change 1st Jan Change
9.63 CAD -1.33% Intraday chart for Canopy Growth Corporation -16.91% +42.46%
Sales 2025 * 303M 220M Sales 2026 * 323M 234M Capitalization 734M 533M
Net income 2025 * -127M -92.2M Net income 2026 * -116M -84.22M EV / Sales 2025 * 3.85 x
Net Debt 2025 * 434M 315M Net Debt 2026 * 517M 375M EV / Sales 2026 * 3.88 x
P/E ratio 2025 *
-7.3 x
P/E ratio 2026 *
-8.13 x
Employees 1,621
Yield 2025 *
-
Yield 2026 *
-
Free-Float 99.73%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.33%
1 week-16.91%
Current month-16.91%
1 month-25.81%
3 months+140.15%
6 months-0.72%
Current year+42.46%
More quotes
1 week
9.54
Extreme 9.54
11.80
1 month
9.54
Extreme 9.54
16.27
Current year
3.74
Extreme 3.74
20.50
1 year
3.74
Extreme 3.74
26.00
3 years
3.74
Extreme 3.74
323.60
5 years
3.74
Extreme 3.74
716.00
10 years
3.74
Extreme 3.74
766.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 18-10-31
Director of Finance/CFO 52 19-12-01
Investor Relations Contact - 15-12-31
Members of the board TitleAgeSince
Chief Executive Officer 60 18-10-31
Chairman 69 20-03-30
Director/Board Member 67 20-03-30
More insiders
Date Price Change Volume
24-06-07 9.63 -1.33% 1,061,643
24-06-06 9.76 -8.36% 1,664,189
24-06-05 10.65 -0.28% 709,047
24-06-04 10.68 -2.29% 1,292,930
24-06-03 10.93 -5.69% 1,482,194

Delayed Quote Toronto S.E., June 07, 2024 at 04:00 pm EDT

More quotes
Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
9.63 CAD
Average target price
8.412 CAD
Spread / Average Target
-12.64%
Consensus